Harfst & Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,898
| Closed | -$231K | – | 105 |
|
|
2024
Q1 | $231K | Sell |
2,898
-47
| -2% | -$3.75K | 0.05% | 102 |
|
|
2023
Q4 | $233K | Hold |
2,945
| – | – | 0.06% | 84 |
|
|
2023
Q3 | $206K | Sell |
2,945
-58
| -2% | -$4.05K | 0.06% | 87 |
|
|
2023
Q2 | $208K | Sell |
3,003
-4,769
| -61% | -$330K | 0.06% | 89 |
|
|
2023
Q1 | $578K | Buy |
7,772
+6
| +0.1% | +$446 | 0.17% | 84 |
|
|
2022
Q4 | $724K | Sell |
7,766
-120
| -2% | -$11.2K | 0.21% | 70 |
|
|
2022
Q3 | $752K | Sell |
7,886
-412
| -5% | -$39.3K | 0.23% | 68 |
|
|
2022
Q2 | $768K | Sell |
8,298
-2,726
| -25% | -$252K | 0.22% | 69 |
|
|
2022
Q1 | $1.12M | Buy |
11,024
+1,199
| +12% | +$121K | 0.26% | 67 |
|
|
2021
Q4 | $1.01M | Sell |
9,825
-600
| -6% | -$61.9K | 0.26% | 64 |
|
|
2021
Q3 | $884K | Buy |
10,425
+20
| +0.2% | +$1.7K | 0.24% | 71 |
|
|
2021
Q2 | $868K | Sell |
10,405
-1,141
| -10% | -$95.2K | 0.25% | 74 |
|
|
2021
Q1 | $868K | Buy |
11,546
+5,453
| +89% | +$410K | 0.26% | 76 |
|
|
2020
Q4 | $416K | Buy |
6,093
+1,189
| +24% | +$81.2K | 0.15% | 93 |
|
|
2020
Q3 | $286K | Buy |
4,904
+216
| +5% | +$12.6K | 0.12% | 102 |
|
|
2020
Q2 | $304K | Buy |
4,688
+35
| +0.8% | +$2.27K | 0.13% | 83 |
|
|
2020
Q1 | $276K | Sell |
4,653
-1
| -0% | -$59 | 0.14% | 81 |
|
|
2019
Q4 | $345K | Sell |
4,654
-76
| -2% | -$5.63K | 0.13% | 76 |
|
|
2019
Q3 | $298K | Buy |
+4,730
| New | +$298K | 0.12% | 78 |
|